home / stock / lgnd / lgnd quote
Last: | $72.47 |
---|---|
Change Percent: | 0.81% |
Open: | $71.93 |
Close: | $72.47 |
High: | $72.95 |
Low: | $71.16 |
Volume: | 137,196 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$72.47 | $71.93 | $72.47 | $72.95 | $71.16 | 137,196 | 04-19-2024 |
$72.52 | $78.7 | $72.52 | $78.7 | $72.5 | 131,220 | 04-18-2024 |
$78.87 | $79.92 | $78.87 | $80.53 | $78.295 | 179,844 | 04-17-2024 |
$79.92 | $79.47 | $79.92 | $81.52 | $79.0575 | 158,485 | 04-16-2024 |
$79.77 | $80.81 | $79.77 | $80.96 | $79.09 | 175,640 | 04-15-2024 |
$81.36 | $81.48 | $81.36 | $81.73 | $80.43 | 171,376 | 04-12-2024 |
$81.43 | $81.42 | $81.43 | $81.56 | $80.575 | 147,248 | 04-11-2024 |
$80.78 | $79.63 | $80.78 | $81.04 | $78.875 | 146,147 | 04-10-2024 |
$81.5 | $79.46 | $81.5 | $81.64 | $78.8887 | 142,118 | 04-09-2024 |
$79.6 | $77.49 | $79.6 | $80.21 | $77.48 | 160,954 | 04-08-2024 |
$77.96 | $77.45 | $77.96 | $78.35 | $76.02 | 165,690 | 04-05-2024 |
$77.98 | $78.01 | $77.98 | $78.87 | $76.925 | 311,838 | 04-04-2024 |
$74.73 | $72.6 | $74.73 | $74.882 | $72.51 | 102,027 | 04-03-2024 |
$73.21 | $73.2 | $73.21 | $73.35 | $72.3 | 122,828 | 04-02-2024 |
$73.6 | $73.35 | $73.6 | $73.62 | $71.215 | 181,067 | 04-01-2024 |
$73.1 | $71.29 | $73.1 | $73.42 | $71.12 | 109,733 | 03-29-2024 |
$73.1 | $71.29 | $73.1 | $73.42 | $71.12 | 109,733 | 03-28-2024 |
$71.27 | $69.26 | $71.27 | $71.85 | $68.8 | 191,807 | 03-27-2024 |
$68.64 | $69.82 | $68.64 | $70.25 | $68.245 | 107,915 | 03-26-2024 |
$69.25 | $71.38 | $69.25 | $71.675 | $68.98 | 107,055 | 03-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Ligand Pharmaceuticals Incorporated Company Name:
LGND Stock Symbol:
NASDAQ Market:
2024-04-12 23:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Captisol-enabled™ Topiramate Injection shown to be a substitute for an oral dose on a one-to-one basis Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its partners at the University of Minnesota (UMN) and CURx Pharmaceuticals, Inc. presented new data on Ca...
Pharmaceutical executive Scott Plesha named CEO Lead product ZELSUVMI expected to be commercially available in late 2024 Ligand Pharmaceuticals (Nasdaq: LGND) today announced the launch of Pelthos Therapeutics (Pelthos), a biopharmaceutical company, and the appointment of season...